Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2014 / Feb / Gains from Games
Data and AI News and Research Technology Omics Genomics & DNA Analysis

Gains from Games

Gamers are better at identifying certain patterns than computer algorithms, so why not use them to pick out breast cancer-related gene profiles?

By Rich Whitworth 02/24/2014 1 min read

Share

If you’ve ever dreamed of piloting your own spaceship through an asteroid belt while simultaneously performing cutting edge cancer research, then “Play to Cure: Genes in Space” is the app for you. While you’re busy plotting your course and harvesting “Element Alpha” in the intergalactic (genetic) landscape, what you are actually doing is inspecting gene copy number variation from state-of-the-art data gathered from the 2012 METABRIC (Molecular Taxonomy of Breast Cancer International Consortium) study (1).

METABRIC looked at patterns in the tumors of nearly two thousand women and concluded that there were at least ten different subtypes of breast cancer, each with its own genetic fingerprint (Figure 1) But that left an ocean of genetic data to crunch.

0214-201-fig1Figure 1. Raw data from the METABRIC study (above) was converted into “Element Alpha” to create an interactive space-scape (left and below).
0214-201-fig.2
0214-201-fig.3

Oscar Rueda from Carlos Caldas’ group (Breast Cancer Functional Genomics, University of Cambridge) was involved in the project. He explains that, “The cancer types have different DNA copy number profiles. In some cases these form a narrow peak that describes the driver gene in that particular subtype; in other cases it is not so clear.” Current statistical methods can detect copy-number aberrations in the genome with an accuracy of 90-95 percent, Rueda says, “But for difficult cases, the human eye usually does a better job. It can spot the patterns in the copy number profile and distinguish whether a real copy number change is happening or if it is
just noise.” The problem is, manual curation of 46,000 plots is not feasible. “Plus, we would still have problems with the inter-rater agreement, due to subjective scoring,” says Reuda. And so, the idea of a video game was born, tapping into the inexhaustible passion for tablets and smartphone games.

“Play to Cure” is available from Apple and Google Play stores and it’s fair to say that it’s addictive – consider it as a much more useful replacement for Flappy Bird. “We expect that with a large number of people analyzing each case, the average results will be more accurate than any statistical method,” says Reuda, “but of course we will have to formally prove it.” If the project is a success, look out for more opportunities to put your game addiction to good use. “I think it will open the door to many other problems that can benefit from crowd sourcing initiatives,” Rueda says.

Can you beat the (meager) success of The Analytical Scientist’s first mission? Asteroids destroyed: 10, Element Alpha: 7120. Post your scores in Comments. And may the force be with you.

0214-201-fig.4

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Christina Curtis et al., “The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups”, Nature 486, 346–352 (2012). DOI:10.1038/nature10983

About the Author(s)

Rich Whitworth

Rich Whitworth completed his studies in medical biochemistry at the University of Leicester, UK, in 1998. To cut a long story short, he escaped to Tokyo to spend five years working for the largest English language publisher in Japan. "Carving out a career in the megalopolis that is Tokyo changed my outlook forever. When seeing life through such a kaleidoscopic lens, it's hard not to get truly caught up in the moment." On returning to the UK, after a few false starts with grey, corporate publishers, Rich was snapped up by Texere Publishing, where he spearheaded the editorial development of The Analytical Scientist. "I feel honored to be part of the close-knit team that forged The Analytical Scientist – we've created a very fresh and forward-thinking publication." Rich is now also Content Director of Texere Publishing, the company behind The Analytical Scientist.

More Articles by Rich Whitworth

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.